THE FORMATION OF METHEMOGLOBIN AND SULFHEMOGLOBIN DURING SULFANILAMIDE THERAPY.
作者信息
Harris J S, Michel H O
机构信息
Department of Pediatrics, Duke University School of Medicine, Durham.
出版信息
J Clin Invest. 1939 Sep;18(5):507-19. doi: 10.1172/JCI101064.
Abstract
摘要
相似文献
1
THE FORMATION OF METHEMOGLOBIN AND SULFHEMOGLOBIN DURING SULFANILAMIDE THERAPY.磺胺类药物治疗期间高铁血红蛋白和硫化血红蛋白的形成
J Clin Invest. 1939 Sep;18(5):507-19. doi: 10.1172/JCI101064.
2
Three-wavelength method for the optical differentiation of methemoglobin and sulfhemoglobin in oxygenated blood.用于在含氧血液中对高铁血红蛋白和硫血红蛋白进行光学区分的三波长方法。
Annu Int Conf IEEE Eng Med Biol Soc. 2017 Jul;2017:4570-4573. doi: 10.1109/EMBC.2017.8037873.
3
Sulfhemoglobinemia after dermal application of DMSO.经皮肤应用二甲基亚砜后出现硫血红蛋白血症。
Vet Hum Toxicol. 1998 Apr;40(2):87-9.
4
Pitfalls in discriminating sulfhemoglobin from methemoglobin.区分硫化血红蛋白和高铁血红蛋白时的陷阱。
Clin Chem. 1997 Jun;43(6 Pt 1):1098-9.
5
SPECTROPHOTOMETRIC DETERMINATION OF ABNORMAL HEMOGLOBIN PIGMENTS IN BLOOD.
Clin Chim Acta. 1965 Feb;11:146-58. doi: 10.1016/0009-8981(65)90209-3.
6
THE ROLE OF NONHEMOGLOBIN PROTEINS AND REDUCED GLUTATHIONE IN THE PROTECTION OF HEMOGLOBIN FROM OXIDATION IN VITRO.非血红蛋白蛋白和还原型谷胱甘肽在体外保护血红蛋白免受氧化中的作用
J Clin Invest. 1964 Jan;43(1):17-26. doi: 10.1172/JCI104889.
7
8
Mechanism of formation of sulphhaemoglobin.硫血红蛋白的形成机制。
Biochim Biophys Acta. 1968 Feb 1;156(1):97-108. doi: 10.1016/0304-4165(68)90108-6.
9
Interpreting sulfhemoglobin and methemoglobin in patients with cyanosis: An overview of patients with M-hemoglobin variants.解读发绀患者中的硫化血红蛋白和高铁血红蛋白：M 血红蛋白变异患者概述。
Int J Lab Hematol. 2021 Aug;43(4):837-844. doi: 10.1111/ijlh.13581. Epub 2021 Jun 6.
10
[Spectrum properties of sulfhemoglobin and a method for its determination].
Klin Wochenschr. 1968 Jul 1;46(13):728-9. doi: 10.1007/BF01731162.
引用本文的文献
1
Blood-Dyscrasia in the Treatment of Venereal Diseases.性病治疗中的血液恶病质
Br J Vener Dis. 1941 Jan;17(1-2):125-65. doi: 10.1136/sti.17.1-2.125.
2
Haemoglobinometry and the Haematocrit: M.R.C. Report.血红蛋白测定法与红细胞压积：医学研究委员会报告。
Br Med J. 1943 Feb 20;1(4285):209-12.
3
Cyanosis of Unusual Origin in Pregnancy: (With report of a case of sulphaemoglobinaemia).孕期罕见原因导致的发绀：（附一例硫化血红蛋白血症病例报告）
Can Med Assoc J. 1944 Apr;50(4):344-9.
4
The oxidation of sulphanilamide and sulphapyridine by hydrogen peroxide.过氧化氢对磺胺和磺胺吡啶的氧化作用。
Biochem J. 1940 May;34(5):636-9. doi: 10.1042/bj0340636.
5
ACUTE HEMOLYTIC ANEMIA FROM THE SULFONAMIDES.磺胺类药物所致急性溶血性贫血
J Clin Invest. 1941 Sep;20(5):593-602. doi: 10.1172/JCI101252.
6
THE OCCURRENCE OF METHEMOGLOBINEMIA DURING SULFANILAMIDE THERAPY.磺胺类药物治疗期间高铁血红蛋白血症的发生情况。
J Clin Invest. 1940 Jan;19(1):123-7. doi: 10.1172/JCI101106.
7
THE IN VITRO FORMATION OF AN OXIDIZING AGENT BY SURVIVING TISSUES AND SULFANILAMIDE.存活组织与磺胺在体外形成氧化剂的过程
J Clin Invest. 1939 Sep;18(5):521-6. doi: 10.1172/JCI101065.
本文引用的文献
1
Methaemoglobinaemia due to Sulphanilamide Therapy.磺胺类药物治疗所致的高铁血红蛋白血症
Can Med Assoc J. 1937 Jul;37(1):62-4.
2
TOXIC MANIFESTATIONS OF SULFANILAMIDE.磺胺类药物的毒性表现
Ann Surg. 1938 Nov;108(5):808-12. doi: 10.1097/00000658-193811000-00002.
3
On sulphhaemoglobin.关于硫血红蛋白。
J Physiol. 1907 Aug 27;36(1):62-7. doi: 10.1113/jphysiol.1907.sp001217.
4
A STUDY OF SOME OF THE PHYSIOLOGICAL EFFECTS OF SULFANILAMIDE. II. METHEMOGLOBIN FORMATION AND ITS CONTROL.磺胺类药物某些生理效应的研究。II. 高铁血红蛋白的形成及其控制
J Clin Invest. 1938 Nov;17(6):699-710. doi: 10.1172/JCI100997.
5
CYANOSIS WITHOUT SULF- OR METHEMOGLOBINEMIA IN PATIENTS RECEIVING SULFANILAMIDE TREATMENT.接受磺胺类药物治疗的患者出现无硫化血红蛋白血症或高铁血红蛋白血症的发绀。
J Clin Invest. 1938 Jul;17(4):445-7. doi: 10.1172/JCI100971.
Zotero 插件